TCRT Alaunos Therapeutics, Inc.
$2.06▼ -3.29%
Healthcare
Other
Volume 377.2K
Avg Volume (10D) 42.52M
Key Metrics & Fundamentals
Market Cap
$7.09M
P/E Ratio
–
Div Yield
0.00%
52W Range
0.72 - 4.50
% vs 50 MA
26.41%
% vs 200 MA
-12.09%
RSI-14
51.8
MACD Histogram
+0.0300
Beta (1Y vs SPY)
1.38
Free Cash Flow
-$300,000
Gross Rev
$0
Gross Profit
$0
EBITDA
-$943,000
COGS
–
Operating Exp
$952,000
Operating Income
-$952,000
EBIT
-$952,000
Pretax Income
-$952,000
Net Income
-$952,000
EPS (Diluted)
-0.41
Price & Volume History
Loading chart…
Recent News
Top Premarket Gainers
MT Newswires · Oct 16, 2026 7:27 AM ET
BC-Most Active Stocks
Associated Press · Oct 14, 2026 10:30 AM ET
Another Paragon spinout goes public through reverse merger
BioPharma Dive · Oct 13, 2026 4:35 PM ET
Top Midday Gainers
MT Newswires · Oct 13, 2026 1:50 PM ET
Alaunos Therapeutics Completes Velaris Acquisition; Shares Surge
MT Newswires · Oct 13, 2026 11:14 AM ET
Alaunos Therapeutics Announces Acquisition of Velaris Therapeutics
GlobeNewswire · Oct 13, 2026 10:31 AM ET
BC-Most Active Stocks
Associated Press · Oct 13, 2026 10:30 AM ET
Paragon Labs Expands Leadership Team with Former Apogee Executives; Velaris Therapeutics Acquired by Alaunos Therapeutics, Inc.
PR Newswire · Oct 13, 2026 7:00 AM ET
Alaunos Therapeutics, Inc. Announces Pricing of Registered Direct Offering priced at-the-market under Nasdaq rules
GlobeNewswire · Sep 18, 2026 9:00 AM ET
Ziopharm: Q2 Earnings Snapshot
Associated Press · Aug 14, 2026 5:56 PM ET
Financial Overview - Income Statement
Quarterly
Dec 2025
See TCRT's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.